Institution Subject number. Demographics Age (yrs) Male (0/1) Race (0/1) Hispanic Non-hispanic AA Asian

Similar documents
Data Collection Tool. Standard Study Questions: Admission Date: Admission Time: Age: Gender:

EAST MULTICENTER STUDY DATA DICTIONARY

4. Which survey program does your facility use to get your program designated by the state?

ACUTE KIDNEY INJURY (AKI) ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...

High Risk + Challenging Trauma Cases. Hawaii. Topics 1/27/2014. David Thompson, MD, MPH. Head injury in the anticoagulated patient.

Adult Reversal of Anticoagulation and Anti-platelet Agents for Life- Threatening Bleeding or Emergency Surgery Protocol

Standardize comprehensive care of the patient with severe traumatic brain injury

EAST MULTICENTER STUDY DATA DICTIONARY. Temporary Intravascular Shunt Study Data Dictionary

Q1 Contact Information

Supplement Table 1. Definitions for Causes of Death

Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture

Transfusion Requirements and Management in Trauma RACHEL JACK

ADVOCATE HEALTHCARE GUIDELINE FOR ANTITHROMBOTIC REVERSAL

EAST MULTICENTER STUDY DATA COLLECTION TOOL

New Antithrombotic and Antiplatelet Drugs in CAD : (Factor Xa inhibitors, Direct Thrombin inhibitors and Prasugrel)

ADMINISTRATIVE CLINICAL Page 1 of 6

PRACTICE GUIDELINE. DEFINITIONS: Mild head injury: Glasgow Coma Scale* (GCS) score Moderate head injury: GCS 9-12 Severe head injury: GCS 3-8

Venous Thromboembolism National Hospital Inpatient Quality Measures

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

The Michigan Trauma Quality Improvement Program. Ann Arbor, MI June 7, 2011

HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Multidisciplinary Geriatric Trauma Care Guideline

A Great Clinical Paradox. Narendranath Epperla MD Sowjanya Bapani MD Steven Yale MD, FACP

a. A pharmacist may order a baseline SCr per protocol

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

VENOUS THROMBOEMBOLISM PHARMACOLOGY. University of Hawai i Hilo DNP Program NURS 603 Advanced Clinical Pharmacology Danita Narciso Pharm D

Guidelines for the Management of Anticoagulant and Anti-Platelet Agent Associated Bleeding Complications in Adults

Datapoint Description On Tab On Report Data Element Name Type Values Default Validation

Delayed Splenic Rupture After Non-Operative Management of Blunt Splenic Injury A AAST Multi-Institutional Prospective Trial Data Collection Tool

Number with pick list. 5/6/2011 Michigan TQIP

Yes No Unknown. Major Infection Information

Study title: Safety of therapeutic anticoagulation in patients with traumatic brain injury: a multicenter prospective observational study

Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks

Venous Thromboembolism Prophylaxis

UPDATES, 2018 NTDS PILOT (PROPOSED CHANGES TO 2020 NTDB DATA DICTIONARY) AND TQIP PROCESS MEASURES. Lita Holdeman, BS, CSTR AOTR Education Chair

Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015

Acute Stroke Protocols Modified- What s New in 2013

Clinical Controversies in Perioperative Medicine

DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.

PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1).

Datapoint Description On Tab On Report Data Element Name Type Values Default

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine


Process Measures Toolkit for 2016 Admissions

Joshua D. Lenchus, DO, RPh, FACP, SFHM Associate Professor of Medicine and Anesthesiology University of Miami Miller School of Medicine

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Prostate Biopsy Alerts

CEREBRO VASCULAR ACCIDENTS

Chapter 1 The Reversing Agents

Orthopedic Admission Hip Fracture Version 2 1/25/2017

Brain vs. Bone: Does fracture fixation technique influence outcomes in patients with traumatic brain injury (TBI)?

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

Thrombolysis administration

Mabel Labrada, MD Miami VA Medical Center

TEVAR for trauma is here to stay: Advances in the Treatment of Blunt Thoracic Aortic Injury

TRAUMA RESUSCITATION. Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital


Nitroglycerin and Heparin Drip Interfacility Protocols

WMC PHARMACY ANTICOAGULATION PROTOCOL Current Revision: July 2017 GENERAL ORDER PROCESSING AND MANAGEMENT

FACTOR Xa AND PAR-1 BLOCKER : ATLAS-2, APPRAISE-2 & TRACER TRIALS

Do s and Don t of DOACs DISCLOSURE

Lutheran Medical Center Department of Surgery

Bladder Trauma Data Collection Sheet

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary

Michael Avant, M.D. The Children s Hospital of GHS

Page 1 of 6. Low 1 (score 0-3) Monitor platelets and signs and symptoms of thrombosis and continue heparin

Asif Serajian DO FACC FSCAI

New Strategies in the Management of Patients with Severe Sepsis

Blood Product Utilization A Mythbusters! Style Review. Amanda Haynes, DO 4/28/18

ECLS Registry Form Extracorporeal Life Support Organization (ELSO)

Guideline for Treatment of Head Injury in the Anticoagulated Patient

Canadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet

Reversal of Anticoagulants at UCDMC

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

Reducing the Use of Reversal Agents in a Community Hospital

October 2017 Pulmonary Embolism

2.5 Other Hematology Consult:

Head injuries. Severity of head injuries

Traumatic Brain Injuries

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

New Oral Anticoagulants

Guide to completing the MODET study CRF

A Comparative Analysisof Male versus Female Breast Cancer in the ACS NSQIP Database

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Supplementary Appendix

Emergent Anticoagulation Reversal

Emergency Room Procedure The first few hours in hospital...

SAMPLE Data Entry Manual for the veds Project

Transcription:

Institution Subject number Demographics Age (yrs) Male (0/1) Race (0/1) Hispanic Non-hispanic AA Asian Co-morbidities (0/1) Hypertension Coronary artery disease If 1: Coronary stents History of cardiac surgery Non-insulin dependent diabetes Chronic alcohol abuse Congestive heart failure CVA/stroke Chronic drug abuse Insulin dependent diabetes Transplant history Psychiatric disorder Myocardial infarction Renal insufficiency (not on dialysis) Renal failure (on dialysis) Asthma Rheumatoid arthritis Parkinson s disease Cirrhosis Seizures COPD/Emphysema Mechanism (0/1) Blunt Fall Found down Motor vehicle crash

Motorcycle crash Recreational vehicle crash Auto vs. Pedestrian Assault Other Penetrating Stab wound GSW Other Injuries ISS AIS Head Face Neck Thorax Abdomen Spine Upper extremity Lower extremity Head injury Epidural hemorrhage Subdural hemorrhage Subarachnoid hemorrhage Intraparenchymal hemorrhage Spinal injury Fracture cervical Associated cord injury Fracture thoracic Associated cord injury Fracture lumbar Associated cord injury Fracture other without cord injury (ICD-10) code Fracture other with cord injury (ICD-10) code Injuries Other (ICD-10) Physiology on admit SBP on admit (mm Hg) SBP <90 (0/1) GCS (score)

GCS <9 (0/1) Base deficit (mmol/l) Hgb (g/dl) Alcohol screen done (0/1) Blood alcohol level (mg/dl) Urine toxicology done (0/1) Utox Negative Utox +cannabis Utox +cocaine Utox +PCP Utox +benzodiazapines Utox +barbiturates Utox +narcotics/opiates Utox +amphetamines Utox +methamphetamines Utox +other Transfer Was pt transferred to your TC? Outcomes Mechanical ventilation (0/1) Days ventilated (days) ICU admission (0/1) ICU-LOS (days) H-LOS (days) Disposition (0/1) Against Medical Advice Jail Psychiatric facility Home Rehab facility Skilled nursing facility Extended care facility Other acute care Facility/transfer Hospice Death <24 hrs >24 hrs Hosp day of death (day) Complications (0/1) Progression of brain injury Progression of neurological deficit Unplanned return to OR

PE DVT GIB Myocardial infarction CHF CVA/TIA AKI ALI ARDS Pneumonia UTI Bacteremia Cellulitis SSI CSF infection Heparin Induced Thrombocytopenia (HIT) Antiplatelet/coagulation Medications ASA (0/1) (<82mg vs >82mg) Clopidogrel (0/1) Prasugrel (0/1) Ticagrelor (0/1) Cangrelor (0/1) Dipyridamole (0/1) Dabigatran (0/1) Rivaroxaban (0/1) Apixaban (0/1) Edoxaban (0/1) Betrixaban (0/1) Other (agent) Labs on admit aptt (sec) PT (sec) INR TEG (if available) Platelet testing (mapping, VerifyNow, aggregometry) Platelet count BUN Creatinine Timing to normalization of coagulation parameters

PT/INR normal on admit aptt normal on admit Platelets normal on admit TEG normal on admit Time to normal PT/INR (hrs) Time to normal aptt (hrs) Time to normal platelets (hrs) Time to normal TEG (hrs) Interventions ICP monitor Bolt/Camino Date placed (Hosp day) Ventriculostomy Date placed (hosp day) Angiography (0/1) Diagnostic Embolization Stent Craniotomy Craniectomy Thoracotomy Sternotomy Laparotomy Surgery Other Timing to intervention (hrs) Time to ICP placement Time to craniotomy Time to craniectomy Time to thoracotomy Time to sternotomy Time to laparotomy Time to surgery other Hold anticoagulant (0/1) Reverse anticoagulant (0/1) Drug specific agent (0/1) Drug used Hemodialysis for reversal Hospital date agent resumed (day) Transfusion PRBC (units first 24hrs)

PRBC (units total) FFP (units first 24hrs) FFP (units total) Platelets (units first 24hrs) Platelets (units total) Cryoprecipitate (first 24hrs) Cryoprecipitate (units total) Factor VIIa (dose first 24hrs) Factor VIIa (dose total) Prothrombin complex (units first 24hrs) Prothrombin complex (units total) Protamine (dose first 24hrs) Protamine (dose total) Tranexamic acid (dose first 24hrs) Tranexamic acid (dose total) DDAVP (dose first 24hrs) DDAVP (dose total) Vitamin K (mg first 24hrs) Vitamin K (mg total) Complications Bleeding requiring intervention (0/1) Re-bleeding (0/1) Transfusion reaction Fever Rash TRALI TACO Anaphylaxis Hemolysis VTE prophylaxis Mechanical (0/1) Date mechanical (Hospital day) Pharmacologic (0/1) Heparin subcutaneous Enoxaparin Dalteparin Heparin infusion Other anticoagulant

Date pharmacological (Hospital day) Definitions Progression of brain injury: increase in size or severity of intracranial hemorrhage on imaging, or new intracranial hemorrhage on repeat imaging Progression of original neurological insult: deterioration or additional loss of function from that noted upon arrival in ED or trauma bay Unplanned return to OR: unexpected and/or unplanned return to the OR for same or similar procedure PE: embolus to the lungs documented by arteriography, nuclear scan or autopsy DVT: venous thrombosis involving the deep venous system confirmed by autopsy, venogram, duplex scan or non-invasive vascular evaluation GIB: secondary hemorrhage from the GI tract causing decrease in hematocrit >5% or requiring blood transfusion MI: acute irreversible myocardial injury and necrosis documented by increased troponin and serial T wave, ST segment or Q wave ECG changes or a diagnostic radionuclide scan CHF: syndrome of shortness of breath, fluid retention and fatigue associated with elevated cardiac filling pressures and inadequate peripheral oxygen delivery caused by cardiac dysfunction CVA/TIA: AKI: Increased SCr> 0.3mg/dL within 48 hours or SCr>1.5 times baseline ALI/ARDS = acute onset of hypoxemia with: Bilateral pulmonary infiltrates on chest x-ray Pulmonary capillary wedge pressure <18mmHg(2.4kPa) ALI=PaO2/FiO2 <300mmHg (40kPA) ARDS=PaO2/FiO2<200mmHg (40kPA) Pneumonia: presence of fever, leukocytosis, gram stain of sputum with predominant organism and white blood cells, chest x-ray with infiltrate and culture demonstrating a pathogen UTI: 50,000 colonies in a clean urine culture and/or presumptive diagnosis that leads to treatment with antibiotics Bacteremia: any positive blood culture excluding isolates that are felt to be contaminants

Cellulitis: skin/soft tissue infection as evidenced by drainage of purulent material from a wound or active treatment of the wound including opening a closed wound, or administering antibiotics for the wound (excluding prophylactic antibiotics) SSI: surgical site infection involving drainage of purulent material from wound requiring opening of a closed wound, or antibiotic therapy (excluding prophylactic antibiotics) CSF infection: positive culture of cerebrospinal fluid, positive culture of CSF, or >50% polymorphonuclear cells on cell count or minimum 50 cells counted or CSF sugar <15% or evidence of meningitis or encephalitis on MRI Heparin Induced Thrombocytopenia: positive immunoassay identifying antibodies against heparin/pf4 or positive serotonin releasing assay (SRA) or heparin-induced platelet aggregation assay (HIPA) Transfusion reactions 1. Fever = temperature 101.5F or 38.5C temporally related to blood transfusion 2. Rash = maculopapular skin lesions or hives temporally related to blood transfusion 3. TRALI = Meets criteria previously stated for ALI/ARDS with hypotension and fever that occurs within 6 hours of blood transfusion and has no other reasonable explanation of pulmonary symptoms. Usually resolves quickly 4. TACO = dyspnea, orthopnea, peripheral edema, rapid increase in blood pressure temporally related to blood transfusion